December 24, 2024 - 23:28

US stocks appeared poised for a subdued opening as investors braced for the final, shortened trading session before the Christmas holiday. The anticipation of a "Santa Claus" rally, traditionally characterized by a surge in stock prices during the final week of December, has led to cautious optimism among traders.
Despite the muted outlook, major indices such as the Nasdaq, S&P 500, and Dow Jones have shown resilience in recent sessions, reflecting a strong year for the markets overall. Analysts suggest that this year's performance has been buoyed by factors such as robust corporate earnings, a resilient labor market, and easing inflation pressures.
As the holiday season approaches, trading volumes are expected to decline, leading to potential volatility. Investors are likely to keep an eye on economic indicators and developments that could influence market sentiment into the new year. With the festive spirit in the air, many are hopeful for a positive close to 2023.
June 7, 2026 - 04:43
Why Pay More for Gold? GLDM Offers the Same Bullion for a Fraction of GLD's CostA 58-year-old investor with $100,000 parked in SPDR Gold Trust (GLD) as a crisis hedge is paying roughly $300 more per year than necessary for the exact same bars of bullion. That is the...
June 6, 2026 - 00:01
The Spill: Why Financial Pros Are Piling Into IWM Right NowAfter years of playing second fiddle to mega-cap tech stocks, small-cap equities are suddenly the center of attention. The iShares Russell 2000 ETF, known by its ticker IWM, is seeing a wave of...
June 5, 2026 - 04:07
Medallion Financial Corp. Exposes ZimCal’s Latest Campaign of Distortion and the Risks of Electing Its Unqualified NomineesMedallion Financial Corp. has issued a sharp rebuttal against ZimCal`s latest proxy fight, accusing the investment firm of running a campaign built on distortions and misaligned incentives. The...
June 4, 2026 - 04:31
OSE Immunotherapeutics Reports Full Year 2025 Audited Consolidated Financial Results and Announces the Filing of its 2025 Universal Registration DocumentOSE Immunotherapeutics SA announced its audited consolidated financial results for the full year 2025 on June 3, 2026. The company confirmed that the audited figures are consistent with the...